The Global Fund Board has approved $57.9 million to finance interventions listed on the Register of Unfunded Quality Demand (UQD) for existing grants in five countries: Algeria (HIV), Ethiopia (TB), Ghana (malaria), Nigeria (TB), and Uzbekistan (TB) grants. The additional funding comes from the reallocation of unutilized funds from other existing Global Fund grants to other countries, termed ‘portfolio optimization’.
Vous êtes ici
Global Fund Board approves additional funding worth $57.9 million through portfolio optimization, for grants in five countries
Global Fund’s management and framework for investments in health systems need significant improvement, OIG says
The Office of Inspector General (OIG) conducted the first audit of the Global Fund’s Resilient and Sustainable Systems for Health (RSSH) investments aiming “to provide reasonable assurance on the adequacy and effectiveness of Global Fund processes for the management of RSSH activities”.
The Kenya Medical Supplies Authority (KEMSA) successfully procures and distributes government, Global Fund, and other donor-funded commodities. Prices obtained by KEMSA are competitive compared to prices obtained by the Global Fund’s Pooled Procurement Mechanism (PPM), stock-outs of health commodities occur rarely, if ever, commodities are delivered in a timely fashion, and inventory is properly managed at all stages of the supply chain.
OIG investigation reveals deficiencies in Global Fund processes for procurement of HIV rapid test kits in eight countries
A proactive investigation undertaken by the Office of the Inspector General (OIG) has identified some deficiencies in the Global Fund’s processes for procuring HIV rapid diagnostic test (RDT) kits. A report on the investigation was released on 31 May 2018.
TRP focuses on gaps in services for key populations in its review of Ethiopia's TB/HIV funding request to the Global Fund
When the Technical Review Panel (TRP) assessed Ethiopia’s TB/HIV funding request last Fall, it considered the request to be technically sound, but expressed concerns related to coverage of key populations.
Ambitious national targets for getting people on treatment often not reflected in grant performance frameworks, GAC says
In its report to the Board on the third batch of grants it recommended for approval, the Grant Approvals Committee (GAC) said that it was very concerned that national programs have ambitious goals to continue scaling up antiretroviral therapy (ART), with the aim of achieving the 90-90-90 targets or even treating all patients diagnosed with HIV – but that these goals are not necessarily reflected in performance frameworks because of “limitation
Donation from Spain in new debt swap
OIG reports good progress in implementing Global Fund grants to Ethiopia, but several problems remain
Innovation for greater impact: exploring domestic resource mobilization efforts in collaboration with the Global Fund
As Aidspan has explored previously, international aid for AIDS, tuberculosis and malaria is plateauing, and a critical transition is underway to find more sustainable approaches to health financing in implementing countries.
Neither the Global Fund Secretariat nor Ethiopia have the necessary systems in place to allow for a national financing strategy model to be implemented at this time. This is the conclusion of a pre-implementation review commissioned by the Secretariat and conducted by the Office of the Inspector General (OIG). The review was conducted between September and November 2014. A report on the review was released on 25 February 2015.